Table 5.
T tests comparing pairs of health states differing in adverse events (N = 182)
| Comparison | Hepatitis C health states | TTO with 10-year time horizon | TTO with 1-year time horizon | ||||
|---|---|---|---|---|---|---|---|
| Mean utilitya | Mean (SD) difference score | P valueb | Mean utilitya | Mean (SD) difference score | P valueb | ||
| E vs I | E. 7 tablets per day plus injectable medication | 0.77 | 0.12 (0.21) | <0.0001 | 0.77 | 0.12 (0.23) | <0.0001 |
| I. health state E + mild anemia | 0.65 | 0.65 | |||||
| E vs J | E. 7 tablets per day plus injectable medication | 0.77 | 0.32 (0.33) | <0.0001 | 0.77 | 0.30 (0.31) | <0.0001 |
| J. health state E + severe anemia | 0.45 | 0.47 | |||||
| E vs K | E. 7 tablets per day plus injectable medication | 0.77 | 0.21 (0.27) | <0.0001 | 0.77 | 0.20 (0.26) | <0.0001 |
| K. health state E + flu-like symptoms | 0.56 | 0.57 | |||||
| E vs L | E. 7 tablets per day plus injectable medication | 0.77 | 0.13 (0.26) | <0.0001 | 0.77 | 0.12 (0.21) | <0.0001 |
| L. health state E + mild rash | 0.65 | 0.66 | |||||
| E vs M | E. 7 tablets per day plus injectable medication | 0.77 | 0.48 (0.44) | <0.0001 | 0.77 | 0.43 (0.41) | <0.0001 |
| M. health state E + severe rash | 0.30 | 0.34 | |||||
| E vs N | E. 7 tablets per day plus injectable medication | 0.77 | 0.47 (0.42) | <0.0001 | 0.77 | 0.45 (0.42) | <0.0001 |
| N. health state E + depression | 0.31 | 0.33 | |||||
| L vs M | L. health state E + mild rash | 0.65 | 0.35 (0.38) | <0.0001 | 0.66 | 0.32 (0.37) | <0.0001 |
| M. health state E + severe rash | 0.30 | 0.34 | |||||
| I vs J | I. health state E + mild anemia | 0.65 | 0.20 (0.26) | <0.0001 | 0.65 | 0.18 (0.22) | <0.0001 |
| J. health state E + severe anemia | 0.45 | 0.47 | |||||
aTTO scores are on a scale anchored with 0 representing dead and 1 representing full health
b P values are based on t tests comparing two utility means